To determine the subset of genes which were differentially overexpressed in MYCN amplified neuroblastoma, we first used RNA-sequencing data from 150 primary tumors (136 of which were high-risk) and stratified them by MYCN expression (Figure 1A). This evidence concerns the gene MYCN and neuroblastoma.